We have 1,937 PhD Projects, Programmes & Scholarships added in the last month

Filter Results 1
Filter Results 1
 Back
 Clear

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding

Filter results
 Back
 Clear filter
Subject
Show 1,937 results
 Back
 Clear filter
Show 1,937 results
 Back
 Clear filter

Show 1,937 results
 Back
 Clear filter
Show 1,937 results
 Back
 Clear filter
Funding Type
Show 1,937 results
Reset

PhD Projects, Programmes & Scholarships

We have 1,937 PhD Projects, Programmes & Scholarships added in the last month

Show more
More details

Transmembrane signal processing in synthetic cells

University College London
London Interdisciplinary Biosciences Consortium (LIDo)
Updated: 30 September 2026 
An iCASE (Industrial Collaborative Award in Science and Engineering) PhD position on ‘transmembrane signal processing in synthetic cells’ is available as part of the London Interdisciplinary Doctoral Programme to start in September 2027. Read more
 Supervisors: Dr M Booth, Prof AB Tabor, Mr JC Calles
 1 December 2026  PhD Research Project  Competition Funded PhD Project (Students Worldwide)
More details
More details

(MCRC Non-Clinical) Molecular déjà vu: understanding RNA and DNA biology for precision therapy in AML

The University of Manchester
Division of Cancer Sciences
Updated: 30 September 2026 
Acute Myeloid Leukaemia (AML) is the most common form of leukaemia in adults with over 3,000 new diagnoses per year in the UK. Currently the management of AML relies heavily on antimetabolite chemotherapies. Read more
 Supervisors: Dr JK Knight, Dr K Batta, Dr D Wiseman
 23 November 2026  PhD Research Project  Competition Funded PhD Project (Students Worldwide)
More details
More details

(MCRC Non-Clinical) Metabolic Drivers of Leukaemia Pathogenesis and Therapy Resistance

The University of Manchester
Division of Cancer Sciences
Updated: 30 September 2026 
Chronic myelomonocytic leukaemia (CMML) is an aggressive myeloid blood cancer defined by expansion of malignant monocytes. Hypomethylating agents (HMAs), such as azacitidine and decitabine, are the only standard-of-care disease-modifying therapies, but 50–70% of patients fail to respond. Read more
 Supervisors: Dr K Batta, Dr D Wiseman, Dr D K Trivedi, Dr CR Rivera Rivera
 23 November 2026  PhD Research Project  Competition Funded PhD Project (Students Worldwide)
More details
More details

(MCRC Non-Clinical) Exploiting Chromosomal Instability Across the Ovarian–Endometrial Axis: Models, Mechanisms and Therapeutic Targeting

The University of Manchester
Division of Cancer Sciences
Updated: 30 September 2026 
The most aggressive ovarian and endometrial cancers converge on a common phenotype. extensive chromosomal instability (CIN) – ongoing chromosomal changes that generate karyotypic heterogeneity within a tumour, linked to poor patient outcomes. Read more
 Supervisors: Dr BB Barnes, Prof S Taylor, Dr SK Kitson
 23 November 2026  PhD Research Project  Competition Funded PhD Project (Students Worldwide)
More details
More details

(MCRC Non-Clinical) Unlocking the power of Geographic Information Systems for Breast Cancer Risk and Prevention

The University of Manchester
Division of Informatics, Imaging and Data Sciences
Updated: 30 September 2026 
At least 30% of breast cancer risk is unexplained by current risk prediction algorithms which incorporate family history, personal history of benign breast disease, polygenic risk scores, breast density, hormonal and reproductive factors, lifestyle and demographic information. Read more
 Supervisors: Prof S Astley, Dr SH Howell, Dr EH Harkess, Dr SR Romanov
 23 November 2026  PhD Research Project  Competition Funded PhD Project (Students Worldwide)
More details
More details

(MCRC Non-Clinical) Development of a UK proton computed tomography system

The University of Manchester
Division of Cancer Sciences
Updated: 30 September 2026 
The advantage of proton beam therapy over conventional X-ray radiotherapy is the increased normal tissue sparing. This advantage, however, is impacted by beam delivery accuracy which, in turn, is impacted by the associated uncertainties. Read more
 Supervisors: Dr M Taylor, Dr AA Aitkenhead
 23 November 2026  PhD Research Project  Competition Funded PhD Project (Students Worldwide)
More details
More details

The role of noisy 5' leaders in Mycobacterium tuberculosis heterogeneity

The Francis Crick Institute
PhD Programme
Updated: 30 September 2026 
A 2027 Crick-University College London Joint PhD project with Eachan Johnson (Crick) and Kristine Arnvig (UCL). Please note. to apply to this project, candidates must be eligible for home tuition fee status. Read more
 Supervisors: Dr E Johnson, Dr Arnvig Arnvig
 2 November 2026  PhD Research Project  Funded PhD Project (Students Worldwide)
More details
More details

Using High-Throughput Operando Spectroscopy to Understand the Factors Controlling Electrocatalyst Performance for Carbon-Neutral Transformations

University College London
Department of Chemistry
Updated: 30 September 2026 
Supervisor. Dr Benjamin Moss. Application deadline. December 20th 2026. Interview date. January 15th 2027. UCL Chemistry Department is offering a fully funded studentship to a highly motivated candidate to start in February 2027. Read more
 Supervisor: Dr BM Moss
 20 December 2026  PhD Research Project  Funded PhD Project (European/UK Students Only)
More details
More details

(MCRC Non-Clinical) Enhancing liquid biopsy with nanoparticles for the detection of oesophageal carcinoma

The University of Manchester
Division of Cancer Sciences
Updated: 30 September 2026 
Liquid biopsies have the potential to transform cancer care by enabling tumour detection and monitoring through a simple blood sample. Read more
 Supervisors: Dr FM Mouliere, Dr MH Hadjidemetriou, Dr SV Valpione, Dr A Clipson
 23 November 2026  PhD Research Project  Competition Funded PhD Project (Students Worldwide)
More details
More details

(MCRC Non-Clinical) Personalising Prostate Cancer Radiotherapy Using Imaging and Genomic Biomarkers

The University of Manchester
Division of Cancer Sciences
Updated: 30 September 2026 
Radiotherapy is an effective treatment for prostate cancer, but men vary widely in their susceptibility to radiation-induced side effects. Read more
 Supervisors: Dr JS Shortall, Dr A McWilliam, Prof AC Choudhury
 23 November 2026  PhD Research Project  Competition Funded PhD Project (Students Worldwide)
More details
More details

(MCRC Non-Clinical) Investigating the role of heterogeneity and plasticity in small cell lung cancer invasion

The University of Manchester
Division of Cancer Sciences
Updated: 30 September 2026 
Small cell lung cancer (SCLC) is among the most aggressive cancers. Approximately 80% of patients present with metastatic disease at which stage treatment options are limited, and median survival <1 year. Read more
 Supervisors: Dr M Baker, Prof A Malliri, Dr K Simpson, Dr Colin Lindsay, Prof C Dive
 23 November 2026  PhD Research Project  Competition Funded PhD Project (Students Worldwide)
More details
More details

(MCRC Non-Clinical) Elucidating progesterone-driven Wnt signalling for breast cancer prevention

The University of Manchester
Division of Cancer Sciences
Updated: 30 September 2026 
Progesterone signalling is essential for normal breast development, but repeated hormone-driven expansion of progenitor cells may also create cellular states that initiate breast tumours. Read more
 Supervisors: Dr B Simoes, Prof R Clarke, Dr S Nagarajan, Dr SH Howell
 23 November 2026  PhD Research Project  Competition Funded PhD Project (Students Worldwide)
More details
More details

Determinants of Clonal Fitness in SF3B1-Mutant Clonal Haematopoiesis

The Francis Crick Institute
PhD Programme
Updated: 30 September 2026 
A 2027 Crick PhD project with Dominique Bonnet. Project background and description. Background. Clonal haematopoiesis (CH) is an age-associated condition in which haematopoietic stem cell (HSC) clones carrying somatic mutations acquire a competitive advantage and progressively expand [1]. Read more
 Supervisor: Dr D Bonnet
 2 November 2026  PhD Research Project  Funded PhD Project (Students Worldwide)
More details
More details

Supramolecular Lipid Nanoparticle Functionalisation Platform for Targeted Delivery of Nucleic Acids

The Francis Crick Institute
PhD Programme
Updated: 30 September 2026 
A 2027 Crick PhD project with Charlie McTernan. Project background and description. We are a synthetic chemistry group working in supramolecular and biological chemistry, and nanotechnology. Read more
 Supervisor: Dr C McTernan
 2 November 2026  PhD Research Project  Funded PhD Project (Students Worldwide)
More details
More details

Tissue immunity and immune memory in response to viral and bacterial lung infections

The Francis Crick Institute
PhD Programme
Updated: 30 September 2026 
A 2027 Crick PhD project with Andreas Wack. Project background and description. We are interested in determinants of disease severity in lung infections including influenza, COVID and bacterial infections. Read more
 Supervisor: Dr A Wack
 2 November 2026  PhD Research Project  Funded PhD Project (Students Worldwide)
More details